As follows from the state register of medicines, the trade name of the drug is Avifavir, and the international non-proprietary or grouping or chemical name is Favipiravir.
Earlier, the Vector Research Center for Virology and Biotechnology said that one of the vaccines for coronavirus could be instilled into the nose.
The Director General of Vektor Rinat Maksyutov also noted that clinical trials of the coronavirus vaccine are planned to begin in late June or early July, and to finish in mid-September.